RAPT Therapeutics (RAPT) Non-Current Assets (2020 - 2024)
Historic Non-Current Assets for Therapeutics (RAPT) over the last 5 years, with Q3 2024 value amounting to $5.9 million.
- Therapeutics' Non-Current Assets fell 5337.36% to $5.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $31.6 million, marking a year-over-year decrease of 4065.74%. This contributed to the annual value of $11.5 million for FY2023, which is 1456.16% down from last year.
- Per Therapeutics' latest filing, its Non-Current Assets stood at $5.9 million for Q3 2024, which was down 5337.36% from $6.7 million recorded in Q2 2024.
- Therapeutics' Non-Current Assets' 5-year high stood at $13.7 million during Q1 2023, with a 5-year trough of $3.0 million in Q3 2021.
- Over the past 5 years, Therapeutics' median Non-Current Assets value was $6.7 million (recorded in 2024), while the average stood at $7.9 million.
- Per our database at Business Quant, Therapeutics' Non-Current Assets skyrocketed by 29079.88% in 2022 and then tumbled by 5337.36% in 2024.
- Over the past 5 years, Therapeutics' Non-Current Assets (Quarter) stood at $3.4 million in 2020, then surged by 67.99% to $5.7 million in 2021, then surged by 138.65% to $13.5 million in 2022, then decreased by 14.56% to $11.5 million in 2023, then plummeted by 49.19% to $5.9 million in 2024.
- Its Non-Current Assets stands at $5.9 million for Q3 2024, versus $6.7 million for Q2 2024 and $7.5 million for Q1 2024.